VIGLIAR, ELENA
 Distribuzione geografica
Continente #
AS - Asia 5.351
NA - Nord America 4.579
EU - Europa 3.648
SA - Sud America 586
AF - Africa 147
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.327
Nazione #
US - Stati Uniti d'America 4.383
SG - Singapore 2.282
RU - Federazione Russa 1.781
VN - Vietnam 1.012
CN - Cina 949
IT - Italia 862
BR - Brasile 464
HK - Hong Kong 448
DE - Germania 248
FR - Francia 185
BD - Bangladesh 155
IN - India 124
FI - Finlandia 115
NL - Olanda 107
GB - Regno Unito 97
CA - Canada 95
JP - Giappone 73
MX - Messico 66
KR - Corea 57
IE - Irlanda 52
AR - Argentina 47
ZA - Sudafrica 42
CI - Costa d'Avorio 35
TH - Thailandia 35
ES - Italia 33
EC - Ecuador 29
PH - Filippine 28
PL - Polonia 27
IQ - Iraq 26
SE - Svezia 25
UA - Ucraina 24
ID - Indonesia 23
AT - Austria 21
LT - Lituania 18
PK - Pakistan 18
TR - Turchia 17
TW - Taiwan 15
JO - Giordania 14
EG - Egitto 12
UZ - Uzbekistan 12
MA - Marocco 11
VE - Venezuela 11
RS - Serbia 10
KE - Kenya 8
PY - Paraguay 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
CL - Cile 7
MY - Malesia 7
NP - Nepal 7
AZ - Azerbaigian 6
CO - Colombia 6
DZ - Algeria 6
JM - Giamaica 6
PE - Perù 6
AL - Albania 5
CZ - Repubblica Ceca 5
LB - Libano 5
RO - Romania 5
BE - Belgio 4
ET - Etiopia 4
IL - Israele 4
SA - Arabia Saudita 4
SY - Repubblica araba siriana 4
XK - ???statistics.table.value.countryCode.XK??? 4
BS - Bahamas 3
BW - Botswana 3
CR - Costa Rica 3
GR - Grecia 3
HR - Croazia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AD - Andorra 2
BO - Bolivia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GD - Grenada 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
IR - Iran 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
MN - Mongolia 2
NI - Nicaragua 2
PA - Panama 2
PT - Portogallo 2
SI - Slovenia 2
TZ - Tanzania 2
ZM - Zambia 2
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
Totale 14.293
Città #
Singapore 1.087
San Jose 904
Ashburn 435
Moscow 434
Hong Kong 432
Chandler 385
Ho Chi Minh City 311
Beijing 277
Naples 234
Hanoi 227
Hefei 180
Santa Clara 162
Los Angeles 136
The Dalles 131
Lauterbourg 117
Millbury 113
Munich 99
Napoli 78
Amsterdam 77
New York 74
Tokyo 61
Des Moines 60
Lawrence 58
Dallas 56
Redondo Beach 50
Boston 48
Orem 47
Haiphong 46
Frankfurt am Main 45
São Paulo 45
Buffalo 43
Milan 43
Da Nang 41
Seoul 41
Princeton 40
Wilmington 40
Helsinki 39
Nanjing 36
Kochi 33
Rome 33
Mexico City 31
Council Bluffs 30
Turku 29
Brooklyn 28
Falkenstein 28
Montreal 27
Atlanta 25
Seattle 25
Chicago 23
Johannesburg 23
Stockholm 23
London 22
Rio de Janeiro 21
Warsaw 21
Ottawa 20
Denver 19
Nuremberg 19
Chennai 18
Phoenix 18
Biên Hòa 17
Toronto 16
Can Tho 15
Nanchang 15
Baghdad 14
Bangkok 14
Hải Dương 14
Amman 13
Lappeenranta 13
Houston 12
Shenyang 12
Tashkent 12
Fairfield 11
Manchester 11
Mumbai 11
San Francisco 11
Valencia 11
Caserta 10
Dublin 10
Falls Church 10
Guangzhou 10
Guayaquil 10
Porto Alegre 10
Redwood City 10
Ankara 9
Hebei 9
New Delhi 9
Poplar 9
Portici 9
Salerno 9
Cairo 8
Curitiba 8
Hangzhou 8
Jiaxing 8
Messina 8
Ninh Bình 8
Pune 8
Santa Maria 8
Thái Bình 8
Washington 8
Belgrade 7
Totale 7.681
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 223
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 188
2-deoxy-2[F-18] fluoro-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma 187
Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21 173
Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer 167
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 160
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 156
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations. 155
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 154
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study 151
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 149
Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation 149
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 148
Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better?. 148
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 148
Ciliated foregut cyst of the pancreas: A benign lesion with elevated CEA levels 147
PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial 146
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 146
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 145
Metabolic flexibility in melanoma: A potential therapeutic target 144
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 143
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life Study 142
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 142
Role of Cytomorphology in the Era of Liquid Biopsy 141
Breast implant associated anaplastic large cell lymphoma (BIA-ALCL): a challenging cytological diagnosis with hybrid PET/MRI staging and follow-up 140
Ultrasonography-guided core-needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front-line biopsies in a multicenter Italian study 139
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 139
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 139
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 138
Digital Examination of LYmph node CYtopathology Using the Sydney system (DELYCYUS). An international, multi-institutional study 136
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 136
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx 135
A challenging case of enteric-type lung adenocarcinoma metastatic to the thyroid harboring RET-fusion diagnosed on fine-needle aspiration 134
Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients 132
Antitumor efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models. 132
The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology 132
Next generation sequencing in cytology 132
CD10 is useful to identify gastrointestinal contamination in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) cytology from pancreatic ductal adenocarcinoma. 130
Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study 130
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens 130
Predictive molecular pathology in the time of COVID-19 130
Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients 128
Methods for actionable gene fusion detection in lung cancer: now and in the future 128
Correspondence in reference to the previously published Epub manuscript by Peter Hokland et al. 'How I treat advanced Hodgkin lymphoma - a global view'. Br J Haematol. 2020;190:837-50 128
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 126
Lymph nodes fine needle cytology in the diagnosis of infectious diseases: clinical settings 125
The evolving role of interventional cytopathology from thyroid FNA to NGS: Lessons learned at Federico II University of Naples 124
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 124
Brca1/2 ngs somatic testing in clinical practice: a short report 124
A novel approach to classification and reporting of lymph node fine-needle cytology: Application of the proposed sydney system 123
Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR 122
Gastric duplication cyst: a rare congenital disease often misdiagnosed in adults. 121
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 121
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test 120
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 120
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 119
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 119
Less frequently mutated genes in colorectal cancer: Evidences from next-generation sequencing of 653 routine cases 118
Sulfur Exafluoride Contrast-Enhanced Ultrasound Showing Early Wash-Out of Marked Degree Identifies Lymphoma Invasion of Spleen with Excellent Diagnostic Accuracy: A Monocentric Study of 260 Splenic Nodules 118
How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases: Insights from the International Molecular Cytopathology Meeting 117
A narrative review of predictive immuno-histo/cyto chemistry in lung cancer: focus on gene fusions and PD-L1 expression 116
Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better? 116
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 116
PD-L1 and beyond: Immuno-oncology in cytopathology 116
Coexistence of Primary Gastric Giant Cell-Rich Leiomyosarcoma and Gastrointestinal Stromal Tumor: Report of a Very Rare Case and Review of the Literature. 114
The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience 114
How should a follicular adenoma with papillary architecture be classified on thyroid FNA? Case report with histological correlation 113
How to prepare cytological samples for molecular testing 113
Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi‐institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist 113
Interobserver variability in cytopathology: How much do we agree? 112
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 112
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 112
Microfluidic chip technology applied to fine-needle aspiration cytology samples for IGH clonality assessment 111
CYTOLOGICAL APPROACH TO THE DIAGNOSIS OF LYMPHOPROLIFERATIVE PROCESSES OF THE ORAL CAVITY 110
Interventional cytopathologist perspective on the Milan System Classification: a study on 929 consecutive salivary gland fine-needle aspirations with a focus on challenging diagnostic categories 109
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine‐needle aspiration of neck paraganglioma 106
Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples? 106
Non lymphomatous clonal B-Cell populations in enlarged lymph nodes in acquired immunodeficiency syndrome 105
Liquid biopsy: A promising tool for driving strategies and predicting failures in patients with classic Hodgkin lymphoma 102
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study 102
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice 102
Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma 100
Navigating the Diagnostic Challenges in Lymph Node Cytology: The Case of Reactive Hyperplasia 99
Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018 99
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 98
Outsourcing cytological samples to a referral laboratory for EGFR testing in non-small cell lung cancer: does theory meet practice? 97
Evaluation of KRAS, NRAS and BRAF mutational status and microsatellite instability in early colorectal carcinomas invading the submucosa (pT1): Towards an in-house molecular prognostication for pathologists? 97
Molecular testing in salivary gland cytopathology: A practical overview in conjunction with the Milan system 96
Fine needle aspiration cytology of a cutaneous metastasis from an extraadrenal paraganglioma: a case report. 94
Lymph node fine needle cytology in the staging and follow-up of cutaneous lymphomas. 94
Lymph node and lymphoid organs fine needle aspiration cytology: historical background. 92
Cytopathology Practice in the COVID-19 Era: Focus on Sample Workload 90
Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience 90
Fine-needle cytology and flow cytometry assessment of reactive and lymphoproliferative processes of the breast. 89
Multimetastatic medullary thyroid carcinoma to the breast: PET/CT--mammographic-US and MR findings. 89
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries 89
Juggling the COVID-19 pandemic: A cytopathology point of view 89
InterobServer AgreeMent in Pd-l1 evaLuatIoN on cytoloGical samples—SAMPLING project: A multi-institutional, international study 87
Epidermal Growth Factor Receptor Test Performed on Liquid-Based Cytology Lung Samples: Experience of an Academic Referral Center. 86
KRAS Mutant Allele Specific Imbalance (MASI) assessment in routine samples of metastatic colorectal cancer patients 86
Totale 12.442
Categoria #
all - tutte 46.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.641


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022605 13 12 12 14 12 15 6 35 57 58 145 226
2022/2023933 105 64 34 65 127 114 7 107 169 74 50 17
2023/2024604 33 112 60 40 21 36 7 86 26 23 88 72
2024/20253.883 167 191 4 36 102 184 398 266 232 479 1.497 327
2025/20267.903 780 540 820 674 1.307 342 961 435 900 551 275 318
Totale 14.602